Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2000
12/27/2000CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors
12/27/2000CN1277865A External application traditional Chinese medicine prepn. for treating virarl deaf
12/27/2000CN1277843A Compound medicinal prepn. for treating acute and chronic nasosinusitis, rhinitis and tympanitis
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166206 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
12/26/2000US6166012 Quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165490 Biological material, method of preparing such materials, uses thereof and products made therefrom
12/26/2000US6164282 Methods for restoring and/or enhancing accommodation in pseudo phakia
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076587A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000WO2000076543A1 Ocular tension lowering composition for topical adminstration
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076522A1 Administration of non-oral androgenic steroids to women
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076499A2 Neuroprotective and retinoprotective ophthalmologic medicines
12/21/2000WO2000076491A1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology
12/21/2000WO2000076452A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044391A3 Plasminogen kringle 4 region fragments and methods of use
12/21/2000DE19925739A1 Therapeutikum mit einem Botulinum-Neurotoxin Agent with a botulinum neurotoxin
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2379048A1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000CA2377431A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376909A1 Neuroprotective and retinoprotective ophthalmologic medicines
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods
12/20/2000EP1060748A1 Remedies for corneal epithelium disturbance
12/20/2000EP1060178A1 Heterocyclic compounds as inhibitors of rotamase enzymes
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000EP1059925A1 Ep2-receptor agonists as neuroprotective agents for the eye
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0778733B1 A basic protein composition for killing or inhibiting microbial cells
12/20/2000CN1277554A Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
12/19/2000US6162818 Respiratory system disorders; crohn's disorder; cardiovascular disorders
12/19/2000US6162445 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
12/19/2000US6162428 hNT-neuron human neuronal cells to replace ganglion cells
12/19/2000US6161544 Methods for accelerated orthokeratology
12/19/2000CA2159787C Dibenzofuran aromatic derivatives; pharmaceutical and cosmetic compositions containing the same
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075130A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074703A2 Therapeutic agent comprising a botulinum neurotoxin
12/14/2000WO2000074682A1 Thrombin inhibitors
12/14/2000WO2000074681A1 Metalloprotease inhibitors
12/14/2000WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
12/14/2000WO2000074649A2 Ophthalmic histamine compositions and uses thereof
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376108A1 Ophthalmic histamine compositions and uses thereof
12/14/2000CA2375985A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
12/14/2000CA2375882A1 Metalloprotease inhibitors
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374654A1 Thrombin inhibitors
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058680A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
12/13/2000EP1058560A1 Topical ophthalmic preparations containing immunosuppressive agents
12/13/2000EP1058553A2 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy
12/13/2000EP0858330B1 Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1059345C External use medicine for treating myopia
12/12/2000US6160129 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6159998 Administered as vasodilators, analgesics, anesthetics, sedatives, and anitspasmodic agents
12/12/2000US6159958 Treatment or prophylaxis of retinal pathology and spinal cord injury
12/12/2000US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159458 Sustained release ophthalmic compositions containing water soluble medicaments
1 ... 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 ... 531